Teva Pharmaceutical Industries (TEVA) Receivables - Other (2014)
Teva Pharmaceutical Industries (TEVA) recorded quarterly Receivables - Other of $125.0 million in Q4 2014.
Teva Pharmaceutical Industries (TEVA) Receivables - Other (2014) Analysis & Trends
Teva Pharmaceutical Industries has disclosed Receivables - Other across 1 years of filings, most recently posting $125.0 million for Q4 2014.
- Quarterly Receivables - Other changed N/A year-over-year to $125.0 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $125.0 million (changed N/A YoY) and the FY2014 annual result came in at $125.0 million, changed N/A from the prior year.
- Receivables - Other was little changed at $125.0 million in Q4 2014.
- Over five years, Receivables - Other peaked at $125.0 million in Q4 2014 and troughed at $125.0 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 125.00 Mn |
| Dec 31, 2014 | 125.00 Mn |